Annual Shareholders Equity
Summary
- Current Value
- As of today, DNLI annual shareholders equity is $1.23B, up +19.28% on
- Historical Performance
- DNLI annual shareholders equity is up +27.79% over the past 3 years, and up +211.40% over the past 5 years
- All-Time High Comparison
- DNLI annual shareholders equity is currently at its all-time high
- 3-Year Low Comparison
- DNLI annual shareholders equity is +19.28% above its 3-year low of $1.03B reached on
- Sector Comparison
- DNLI annual shareholders equity is higher than 88.46% of companies in Healthcare sector
Shareholders Equity Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Shareholders Equity | $1.23B | +19.3% | +27.8% | +211.4% | +3663.5% | |
| Quarterly Shareholders Equity | $926.20M | -29.8% | +14.2% | +5.0% | – | |
| Price | $17.07 | -19.7% | -40.9% | -78.7% | – | |
| Annual Total Assets | $1.37B | +19.1% | -2.1% | +148.4% | +3646.1% | |
| Annual Total Liabilities | $144.50M | +17.5% | -67.3% | -8.7% | +3504.3% | |
| Annual Retained Earnings | -$1.54B | -37.9% | -138.6% | -261.6% | -9028.0% | |
| Annual Book Value | $1.23B | +19.3% | +27.8% | +211.4% | +7965.4% | |
| PB Ratio | 2.88 | +15.7% | -23.6% | -65.6% | – | |
| Market Cap | $3B | -13.0% | -32.1% | -72.4% | – |
Shareholders Equity Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.23B | at high | |
| 5Y | $1.23B | at high | |
| All | $1.23B | at high |
Shareholders Equity Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.03B | +19.3% | |
| 5Y | $962.29M | +27.8% | |
| All | $32.67M | +3663.5% |
Shareholders Equity History
| Year | Value | Change |
|---|---|---|
| $1.23B | +19.3% | |
| $1.03B | -1.1% | |
| $1.04B | +8.3% | |
| $962.29M | -16.4% | |
| $1.15B | +191.4% |
| Year | Value | Change |
|---|---|---|
| $394.89M | -27.8% | |
| $546.85M | +17.4% | |
| $465.80M | +83.0% | |
| $254.52M | +679.0% | |
| $32.67M | - |
FAQ
What is the current annual shareholders equity of DNLI?
As of today, DNLI annual shareholders equity is $1.23B
What is 1-year change in DNLI annual shareholders equity?
DNLI annual shareholders equity is up +19.28% year-over-year
What is 3-year change in DNLI annual shareholders equity?
DNLI annual shareholders equity is up +27.79% over the past 3 years
How far is DNLI annual shareholders equity from its all-time high?
DNLI annual shareholders equity is currently at its all-time high
How does DNLI annual shareholders equity rank versus sector peers?
DNLI annual shareholders equity is higher than 88.46% of companies in Healthcare sector
When is DNLI next annual earnings release?
The next annual earnings release for DNLI is on
Quarterly Shareholders Equity
Summary
- Current Value
- As of today, DNLI quarterly shareholders equity is $926.20M, down -9.82% on
- Historical Performance
- DNLI quarterly shareholders equity is down -29.75% year-over-year, and up +14.16% over the past 3 years
- All-Time High Comparison
- DNLI quarterly shareholders equity is currently -36.36% below its historical high of $1.46B set on
- 3-Year Low Comparison
- DNLI quarterly shareholders equity is at its 3-year low
- Sector Comparison
- DNLI quarterly shareholders equity is higher than 86.05% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Shareholders Equity | $926.20M | -9.8% | -29.8% | +14.2% | +5.0% | |
| Annual Shareholders Equity | $1.23B | – | +19.3% | +27.8% | +211.4% | |
| Price | $17.07 | +9.1% | -19.7% | -40.9% | -78.7% | |
| Quarterly Total Assets | $1.06B | -9.5% | -27.4% | -14.0% | -1.4% | |
| Quarterly Total Liabilities | $129.42M | -7.0% | -4.5% | -68.9% | -31.1% | |
| Quarterly Retained Earnings | -$1.92B | -7.1% | -35.0% | -120.5% | -220.9% | |
| Quarterly Book Value | $926.20M | -9.8% | -29.8% | +14.2% | +5.0% | |
| PB Ratio | 2.88 | +16.1% | +15.7% | -23.6% | -65.6% | |
| Market Cap | $3B | +16.2% | -13.0% | -32.1% | -72.4% |
Quarterly Shareholders Equity Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.23B | N/A | -24.7% |
| 3Y | $1.46B | -36.4% | |
| 5Y | $1.46B | -36.4% | |
| All | $1.46B | -36.4% |
Quarterly Shareholders Equity Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $926.20M | at low | |
| 3Y | $926.20M | at low | |
| 5Y | $811.30M | +14.2% | |
| All | $193.14M | +379.6% |
Quarterly Shareholders Equity History
FAQ
What is the current quarterly shareholders equity of DNLI?
As of today, DNLI quarterly shareholders equity is $926.20M
What is DNLI quarterly shareholders equity most recent change?
DNLI quarterly shareholders equity was down -9.82% on September 30, 2025
What is 1-year change in DNLI quarterly shareholders equity?
DNLI quarterly shareholders equity is down -29.75% year-over-year
How far is DNLI quarterly shareholders equity from its all-time high?
DNLI quarterly shareholders equity is currently -36.36% below its historical high of $1.46B set on March 31, 2024
How does DNLI quarterly shareholders equity rank versus sector peers?
DNLI quarterly shareholders equity is higher than 86.05% of companies in Healthcare sector
When is DNLI next earnings release?
The next earnings release for DNLI is on
Shareholders Equity Formula
Data Sources & References
- DNLI Official Website www.denalitherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1714899/000171489925000193/0001714899-25-000193-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1714899/000171489925000066/0001714899-25-000066-index.htm
- DNLI Profile on Yahoo Finance finance.yahoo.com/quote/DNLI
- DNLI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dnli
